| Statin Adverse Effects | 2008/01/01 | English | 472 |
| Endogenous and Exogenous Cardiac Glycosides and their Mechanisms of Action | 2007/01/01 | English | 162 |
| Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor | 2013/06/20 | English | 151 |
| Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus | 2011/04/01 | English | 135 |
| The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway | 2014/08/27 | English | 131 |
| Current Overview on Hypercoagulability in COVID-19 | 2020/08/04 | English | 118 |
| Interactions Between Grapefruit Juice and Cardiovascular Drugs | 2004/01/01 | English | 117 |
| Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects | 2013/11/26 | English | 116 |
| Beyond Low-Density Lipoprotein | 2005/01/01 | English | 113 |
| Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies | 2013/01/17 | English | 110 |
| Cancer of the Heart | 2003/01/01 | English | 110 |
| Management of Statin Intolerance in 2018: Still More Questions Than Answers | 2018/01/09 | English | 108 |
| Bacterial Pericarditis | 2005/01/01 | English | 104 |
| The Role of the Platelet in the Pathogenesis of Atherothrombosis | 2005/01/01 | English | 95 |
| Use of 24-Hour Ambulatory Blood Pressure Monitoring to Assess Antihypertensive Efficacy | 2005/01/01 | English | 95 |
| The Role of Paraoxonase 1 Activity in Cardiovascular Disease | 2004/01/01 | English | 91 |
| Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects | 2019/01/14 | English | 88 |
| Testosterone and Atherosclerosis in Aging Men | 2005/01/01 | English | 86 |
| Cilostazol | 2003/01/01 | English | 84 |
| COVID-19 Pandemic: Cardiovascular Complications and Future Implications | 2020/06/23 | English | 82 |
| Role of Vascular Inflammation in Coronary Artery Disease: Potential of Anti-inflammatory Drugs in the Prevention of Atherothrombosis | 2014/11/05 | English | 80 |
| Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease | 2017/10/12 | English | 79 |
| Calcium Intake and Risk of Cardiovascular Disease | 2012/04/01 | English | 79 |
| Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa | 2016/01/09 | English | 75 |
| Compliance with Antihypertensive Therapy in the Elderly | 2008/01/01 | English | 74 |
| Dyslipidemia in Visceral Obesity | 2004/01/01 | English | 72 |
| Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial | 2015/09/18 | English | 71 |
| Drug Treatment of Acute Ischemic Stroke | 2013/02/01 | English | 69 |
| Clinical Pharmacology and Cardiovascular Safety of Naproxen | 2016/11/08 | English | 68 |
| The Real Role of β-Blockers in Daily Cardiovascular Therapy | 2017/03/29 | English | 67 |